ArticleJournal of diabetes science and technology2008
Continuous glucose monitoring: changing diabetes behavior in real time and retrospectively.
Article in Journal of diabetes science and technology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 17 citations in OpenAlex.
- Estimating plasma glucose with the FreeStyle Libre Pro continuous glucose monitor during oral glucose tolerance tests in youth without diabetes.Pediatric diabetes · 2019Trial
- An alternative sensor-based method for glucose monitoring in children and young people with diabetes.Archives of disease in childhood · 2017Trial
- Performance evaluation of a continuous glucose monitoring system under conditions similar to daily life.Journal of diabetes science and technology · 2013Trial
- Acceptability and usability of continuous glucose monitoring systems in older adults aged 75 years and older with diabetes.BMC geriatrics · 2025Article
- Effect of FSL-CGM on Maternal and Neonatal Outcomes in GDM: A Propensity Score Matching Study in Hangzhou, China.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025Article
- Glucose Extremes and Cognitive Function: A Review of the Neurological Impacts of Hypoglycemia and Hyperglycemia in Type 1 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
- The role of continuous glucose monitoring in physical activity and nutrition management: perspectives on present and possible uses.Physical activity and nutrition · 2023Article
- Continuous Glucose Monitoring As a Behavior Modification Tool.Clinical diabetes : a publication of the American Diabetes Association · 2020Article
- Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes.Diabetes technology & therapeutics · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Results of both the Diabetes Control and Complications Trial and the United Kingdom Prospective Diabetes Studies supported the role of tight glucose control in reducing long-term complications of diabetes. There is further evidence that glycemic variability may be better correlated with the risk for complications than sustained hyperglycemia. These studies reinforce the need to work toward improved glucose control with minimal variability in patients with diabetes. Continuous glucose monitoring technology offers a means of obtaining a more complete picture of glucose patterns and can be used to aid in identifying trends in glycemic variability, especially overnight and after meals when blood glucose testing is not usually performed. Increased access to retrospective trends, the addition of real-time glucose alarms, and prospective trend data can be advantageous in motivating and evaluating behavior change.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.